Try free for 30 days
-
The Hard Sell
- Crime and Punishment at an Opioid Startup
- Narrated by: Mike Chamberlain
- Length: 9 hrs and 16 mins
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Buy Now for $19.99
No valid payment method on file.
We are sorry. We are not allowed to sell this product with the selected payment method
Publisher's Summary
Soon to be the major motion picture Pain Hustlers starring Emily Blunt and Chris Evans streaming on Netflix
‘A pacey crime caper set against the backdrop of the opioid crisis . . . When I tell you that reading The Hard Sell is like watching a Scorsese film, you will assume I am exaggerating. Pick it up and tell me I’m wrong.' - Patrick Radden Keefe, The New York Times
In the early 2000s, John Kapoor had already amassed a small fortune in pharmaceuticals when he founded Insys Therapeutics. A boom time for painkillers, he had developed a novel formulation of fentanyl, the most potent opioid on the market.
Kapoor, a brilliant scientist with relentless business instincts, was eager to make the most of his innovation. But there was a problem: the drug was approved only for cancer patients in dire condition. So he recruited an avaricious team, who employed a variety of deceptive techniques, from falsifying patient records to deceiving insurance companies. Insys became a Wall Street sensation. That is, until insiders reached their breaking point and blew the whistle, sparking a sprawling investigation in the government’s fight to hold the drug industry accountable in the spread of addictive opioids.
With colourful characters and true suspense, The Hard Sell lays bare the pharma playbook. Evan Hughes offers a bracing look not just at Insys, but at how opioids are sold at the point they first enter the national bloodstream – in the doctor’s office . . .
What listeners say about The Hard Sell
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
-
Overall
-
Performance
-
Story
- Nancy
- 30-01-2024
Excellent account and narrator has nice voice
Excellent account
Informative to hear about another drug company other than heavily publicised Purdue pharma
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!